Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis

Jemal, 2010, Cancer statistics, 2010, CA: A Cancer Journal for Clinicians, 60, 277, 10.3322/caac.20073

Brookfield, 2009, Survival disparities among African American women with invasive bladder cancer in Florida, Cancer, 115, 4196, 10.1002/cncr.24497

Mallin, 2011, Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007), Journal of Urology, 185, 1631, 10.1016/j.juro.2010.12.049

Prout, 2000, Bladder cancer: race differences in extent of disease at diagnosis, Cancer, 89, 1349, 10.1002/1097-0142(20000915)89:6<1349::AID-CNCR20>3.0.CO;2-D

Ward, 2010, The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database, Cancer Journal, 16, 614, 10.1097/PPO.0b013e3181ff2aec

Leissner, 2000, Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis, BJU International, 85, 817, 10.1046/j.1464-410x.2000.00614.x

Hussain, 2009, Bladder cancer: narrowing the gap between evidence and practice, Journal of Clinical Oncology, 27, 5680, 10.1200/JCO.2009.23.6901

Dhar, 2008, Outcome after radical cystectomy with limited or extended pelvic lymph node dissection, Journal of Urology, 179, 873, 10.1016/j.juro.2007.10.076

Lamm, 1991, A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette–Guerin for transitional-cell carcinoma of the bladder, New England Journal of Medicine, 325, 1205, 10.1056/NEJM199110243251703

Lamm, 1995, Randomized intergroup comparison of bacillus Calmette–Guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study, Urologic Oncology, 1, 119, 10.1016/1078-1439(95)00041-F

Underwood, 2006, Gender and geographic influence on the racial disparity in bladder cancer mortality in the US, Journal of the American College of Surgeons, 202, 284, 10.1016/j.jamcollsurg.2005.09.009

Scosyrev, 2009, Sex and racial differences in bladder cancer presentation and mortality in the US, Cancer, 115, 68, 10.1002/cncr.23986

Prout, 2004, Survival experience of black patients and white patients with bladder carcinoma, Cancer, 100, 621, 10.1002/cncr.11942

Pollack, 1995, The relationship of local control to distant metastasis in muscle invasive bladder cancer, Journal of Urology, 154, 2059, 10.1016/S0022-5347(01)66693-X

Gore, 2010, Use of radical cystectomy for patients with invasive bladder cancer, Journal of the National Cancer Institute, 102, 802, 10.1093/jnci/djq121

SEER. Surveillance epidemiology and end results. http://seer.cancer.gov/about/; 2010.

Zippin, 1995, Completeness of hospital cancer case reporting from the SEER program of the National Cancer Institute, Cancer, 76, 2343, 10.1002/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#

Kim, 2000, Permutation tests for joinpoint regression with applications to cancer rates, Statistics in Medicine, 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z

Devesa, 1995, Graphical presentation of trends in rates, American Journal of Epidemiology, 141, 300, 10.1093/aje/141.4.300

Taylor, 2006, Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study, Urology, 68, 804, 10.1016/j.urology.2006.04.019

Measurement of Progress Against Cancer, 1990, Extramural committee to assess measures of progress against cancer, Journal of the National Cancer Institute, 82, 825, 10.1093/jnci/82.10.825

Welch, 2000, Are increasing 5-year survival rates evidence of success against cancer?, Journal of the American Medical Association, 283, 2975, 10.1001/jama.283.22.2975

Bailar, 1997, Cancer undefeated, New England Journal of Medicine, 336, 1569, 10.1056/NEJM199705293362206

Chow, 2008, Contemporary epidemiology of renal cell cancer, Cancer Journal, 14, 288, 10.1097/PPO.0b013e3181867628

Chow, 1999, Rising incidence of renal cell cancer in the United States, Journal of the American Medical Association, 281, 1628, 10.1001/jama.281.17.1628

Elias, 2010, High-risk patients with hematuria are not evaluated according to guideline recommendations, Cancer, 116, 2954, 10.1002/cncr.25048

Mungan, 2000, Gender differences in stage distribution of bladder cancer, Urology, 55, 368, 10.1016/S0090-4295(99)00481-1

Najari, 2012, Sex disparities in cancer mortality: the risks of being a man in the United States, Journal of Urology

Mungan, 2000, Gender differences in stage-adjusted bladder cancer survival, Urology, 55, 876, 10.1016/S0090-4295(00)00523-9

Donat, 2009, Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality, Journal of the National Comprehensive Cancer Network, 7, 40, 10.6004/jnccn.2009.0003

David, 2009, Surveillance of urothelial carcinoma: stage and grade migration, 1993–2005 and survival trends, 1993–2000, Cancer, 115, 1435, 10.1002/cncr.24147

Nieder, 2008, Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease, Journal of Urology, 179, 491, 10.1016/j.juro.2007.09.082

Gandini, 2008, Tobacco smoking and cancer: a meta-analysis, International Journal of Cancer, 122, 155, 10.1002/ijc.23033

Reulen, 2008, A meta-analysis on the association between bladder cancer and occupation, Scandinavian Journal of Urology and Nephrology: Supplementum, 64, 10.1080/03008880802325192

Koebnick, 2008, Body mass index: physical activity, and bladder cancer in a large prospective study, Cancer Epidemiology, Biomarkers & Prevention, 17, 1214, 10.1158/1055-9965.EPI-08-0026